- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/50 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
Patent holdings for IPC class C07D 215/50
Total number of patents in this class: 99
10-year publication summary
|
6
|
2
|
6
|
1
|
6
|
3
|
6
|
3
|
13
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3401 |
8 |
| HMI Medical Innovations, LLC | 14 |
8 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
6 |
| Bayer Pharma AG | 1048 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2915 |
5 |
| Novartis AG | 10612 |
2 |
| Bayer Cropscience AG | 1983 |
2 |
| The Trustees of Princeton University | 1216 |
2 |
| UCB Biopharma SPRL | 353 |
2 |
| Wyeth | 309 |
2 |
| Kayothera, Inc. | 9 |
2 |
| Shandong Yuanlitai Medical Technology Co., Ltd. | 4 |
2 |
| Codagen Biosciences, Inc. | 4 |
2 |
| Bristol-myers Squibb Company | 4826 |
1 |
| F. Hoffmann-La Roche AG | 7937 |
1 |
| Hoffmann-La Roche Inc. | 3546 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5795 |
1 |
| Board of Regents, The University of Texas System | 5946 |
1 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10954 |
1 |
| The General Hospital Corporation | 4801 |
1 |
| Other owners | 44 |